All News

A doctor reflected on what it was like treating patients with myeloproliferative neoplasms years ago and how much treatments have improved.

The Gilotrif-Erbitux treatment combination demonstrated antitumor activity in patients with EGFR exon 20 insertion-positive NSCLC, according to a recent study.

Retevmo as a treatment for patients with advanced RET-mutant medullary thyroid cancer “is very exciting,” as treatment options were previously limited, an expert told CURE®.

About four years ago, I wrote a post called "All the Answers" where I discussed the weight of uncertainty after cancer.

The use of telemedicine over in-person oncology visits did not lead to a decrease in advance care planning or an increase in unplanned hospital visits.

CURE shares the top stories in breast cancer, which focus on topics like treatment decisions, feelings on awareness months and books focused on breast reconstruction.

Dr. Heather Parsons of Dana-Farber Cancer Institute explains how a liquid biopsy could help patients with breast cancer and their care teams learn vital information.

When the IV was empty, the transplant nurse unhooked me and said “Mr. Katz, Happy Birthday."

Long-term cancer survivors experience diabetes at similar rates as individuals who are cancer-free, but cancer survivors with diabetes face a potentially higher risk of death, researchers have found.

Dr. Douglas Tremblay of the Ichan School of Medicine explains the necessity of cytoreductive therapy for patients with MPNs such as essential thrombocythemia and polycythemia vera.

Last night, my husband asked what I wanted for Christmas.

After being diagnosed with essential thrombocythemia, Marilyn Kay Edwards was not told much about her disease.

Last Christmas, Cathy McQueen didn’t “feel so great” and noticed a strange indent on her right breast — quickly finding out she had a form of breast cancer.

I heard some bad comments and had scary thoughts after being diagnosed with breast cancer, but the good outweighed the bad.

I had never donated to St. Jude’s Hospital before, even though I’d had cancer twice.

For patients with myeloproliferative neoplasms, it is essential to have an open relationship with oncology nurses, an expert explained.

The Food and Drug Administration (FDA) has granted Fast Track Designation to the investigational adenovirus CAN-2409 plus prodrug Valtrex for the treatment of patients with pancreatic ductal adenocarcinoma.

A phase 2a trial administered the novel drug HT-6184 to its first patient with lower-risk myelodysplastic syndromes.

Patients with Down syndrome and B-cell acute lymphoblastic leukemia tended to have higher rates of treatment-related deaths and poorer overall survival than those without Down syndrome.

When I received my CURE magazine last week, I was fascinated to see a red sticker on the cover indicating it was the lung cancer special edition.

As ‘Big Bang Theory’ star Kate Micucci announced that she is cancer-free and ‘Married at First Sight’ dating coach Mel Schilling announced her cancer diagnosis, here is what’s happening in the oncology space this week.

One expert explained how nurses have “opportunities to get to talk with patients and their loved ones in ways that you don't (get) when you're in the time crunch of an appointment with your oncologist,” and how that can impact end-of-life care.

Treatment with Welireg — now approved by the FDA — helped shrink and stabilize tumors from metastatic renal cell carcinoma with minimal side effects, a patient told CURE®.

Patients with relapsed/refractory large B-cell lymphoma treated with CAR-T cell therapy and bendamustine chemotherapy, experienced lower rates of survival and response as well as shorter times until progression, according to recent study findings.

I spent a week during last Christmas in the oncology ward of a sprawling university hospital in the Midwest.

A treatment combination of avutometinib and defactinib is being evaluated in a new phase 3 trial for patients with low-grade serous ovarian cancer.

An expert explained what ROS1-positive non-small cell lung cancer is and why it is important to identify mutations like ROS1 through genetic sequencing.